CureVac N.V (NASDAQ: CVAC) Now Carries A 12-Month Price Target Of $37.
CureVac N.V (NASDAQ:CVAC)’s traded shares stood at 16.73 million during the latest session, with the company’s beta value hitting 2.49. At the last check today,
CureVac N.V (NASDAQ:CVAC)’s traded shares stood at 16.73 million during the latest session, with the company’s beta value hitting 2.49. At the last check today,
During the last session, CureVac N.V (NASDAQ:CVAC)’s traded shares were 0.85 million, with the beta value of the company hitting 2.51. At the end of
In the last trading session, 1.03 million shares of the CureVac N.V (NASDAQ:CVAC) were traded, and its beta was 2.45. Most recently the company’s share
In the latest trading session,, 0.46 million CureVac N.V (NASDAQ:CVAC) shares changed hands as the company’s beta touched 2.41. With the company’s most recent per
During the last session, CureVac N.V (NASDAQ:CVAC)’s traded shares were 0.62 million, with the beta value of the company hitting 2.43. At the end of
© 2024, Powered by Smart TechOne